Ending Federal Funding for Invasive Tests on Dogs and Cats
Read here
Breaking: FDA Takes Crucial Step to Accelerate Use of Alternatives to Animal Testing
Read here
The Fight to Close America’s Largest Dog Breeder for Lab Tests
Read here
Marshall BioResources, with Its 20,000 Captive Beagles, in the Spotlight
Read here
A National Primate Testing Facility Makes a Moral U-Turn
Read here

The Latest News

Urge Congress

to end taxpayer-funded dog and cat experiments
Here

The current state at FDA

Outdated Regulations

FDA must initiate rulemaking so outdated regulations comport with the revised statute and Congressional intent.

Deliberate Ambiguity at FDA

Current FDA programs to evaluate and accept nonanimal test methods are vague, ineffective, top-heavy, and lack transparency, failing to set up the agency or drug developers for success. FDA must end its deliberate ambiguity practice regarding the use of animals in preclinical research.

the path forward

Regulatory Clarity

FDA must create a clear pathway for regulatory acceptance of nonanimal test methods.

Break the status quo

FDA must act expeditiously to change the drug development paradigm as Congress intended. Otherwise, the 90 to 95% failure rate in clinical trials of drugs that pass animal tests for safety and efficacy fail in human trials will continue.

Center for a Humane Economy is the first non-profit animal welfare organization that focuses on influencing the conduct of corporations to forge a humane economic order.

Donate
Facebook
Contact Us

© 2026 Center for a Humane Economy | All Rights Reserved